Detalles de la búsqueda
1.
Real-World Outcomes and Value of First-Line Therapy for Metastatic Non-Small Cell Lung Cancer.
Cancer Invest
; 38(10): 608-617, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-33107767
2.
Cost of Disease Progression in Patients with Metastatic Breast, Lung, and Colorectal Cancer.
Oncologist
; 24(9): 1209-1218, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30796156
3.
Cost of Disease Progression in Patients with Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia, and Non-Hodgkin's Lymphoma.
Oncologist
; 24(9): 1219-1228, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30808814
4.
Comparative analysis of survival, treatment, cost and resource use among patients newly diagnosed with brain metastasis by initial primary cancer.
J Neurooncol
; 114(1): 117-25, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23700325
5.
Patterns of colorectal cancer screening and adherence rates among an average-risk population enrolled in a national health insurance provider during 2009-2018 in the United States.
Prev Med Rep
; 36: 102497, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38116257
6.
Patterns of initial colorectal cancer screenings after turning 50 years old and follow-up rates of colonoscopy after positive stool-based testing among the average-risk population.
Curr Med Res Opin
; 39(1): 47-61, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36017620
7.
Evaluation of medication compliance in patients on antidepressants at an outpatient tertiary cancer center setting.
J Oncol Pharm Pract
; 17(2): 131-5, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20179166
8.
Real-World Treatment Patterns Among Patients Initiating Small Molecule Kinase Inhibitor Therapies for Thyroid Cancer in the United States.
Adv Ther
; 36(4): 896-915, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30820872
9.
A retrospective analysis of delays in the diagnosis of lung cancer and associated costs.
Clinicoecon Outcomes Res
; 9: 261-269, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28553128
10.
Reduction in Smad2/3 signaling enhances tumorigenesis but suppresses metastasis of breast cancer cell lines.
Cancer Res
; 63(23): 8284-92, 2003 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-14678987
11.
ReCAP: Treatment Patterns and Cost of Care Associated With Initial Therapy Among Patients Diagnosed With Operable Early-Stage Human Epidermal Growth Factor Receptor 2-Overexpressed Breast Cancer in the United States: A Real-World Retrospective Study.
J Oncol Pract
; 12(2): 159-67, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26395563
12.
Health care utilization and risk of infection and bleeding among patients with myelodysplastic syndromes with/without transfusions, and with/without active therapy.
Leuk Lymphoma
; 55(5): 1119-25, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23841504
13.
Age distribution of patients with advanced non-melanoma skin cancer in the United States.
Arch Dermatol Res
; 305(9): 845-50, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23604961
14.
The burden of metastatic melanoma: treatment patterns, healthcare use (utilization), and costs.
Melanoma Res
; 23(2): 159-66, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23370422
15.
Healthcare costs, treatment patterns, and resource utilization among pancreatic cancer patients in a managed care population.
J Med Econ
; 16(12): 1379-86, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24074258
16.
Corroboration of claims algorithm for second-line costs of metastatic colorectal cancer treatment with targeted agents.
J Med Econ
; 16(8): 1071-81, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23777222
17.
Breast cancer cells induce stromal fibroblasts to express MMP-9 via secretion of TNF-alpha and TGF-beta.
J Cell Sci
; 118(Pt 10): 2143-53, 2005 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15855236
18.
SB-505124 is a selective inhibitor of transforming growth factor-beta type I receptors ALK4, ALK5, and ALK7.
Mol Pharmacol
; 65(3): 744-52, 2004 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-14978253
Resultados
1 -
18
de 18
1
Próxima >
>>